An international team of researchers, led by Massachusetts General Hospital and Harvard Medical School, has conducted a meta-analysis revealing that women with high β-amyloid (Aβ) exhibit significantly faster tau accumulation in key brain regions compared to men. Findings suggest that sex differences in Alzheimer’s disease (AD) pathology may influence treatment efficacy, prompting a need for sex-specific therapeutic strategies.